Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of Muscarinic Acetylcholine m1 and m4 Receptor Blockade on Dyskinesia in the Hemi-Parkinsonian Rat
Nicole Chambers, Samantha M. Meadows, Anne Taylor, et al.
Neuroscience (2019) Vol. 409, pp. 180-194
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Levodopa-Induced Dyskinesia in Parkinson’s Disease: Pathogenesis and Emerging Treatment Strategies
Destany K. Kwon, Mohit Kwatra, Jing Wang, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3736-3736
Open Access | Times Cited: 78
G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders
Thian‐Sze Wong, Guangzhi Li, Shiliang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 60
Ultrahigh peroxidase-like catalytic performance of Cu–N4 and Cu–N4S active sites-containing reduced graphene oxide for sensitive electrochemical biosensing
Phan Gia Le, Xuan Ai Le, Hai Sang Duong, et al.
Biosensors and Bioelectronics (2024) Vol. 255, pp. 116259-116259
Closed Access | Times Cited: 9
Targeting the M1 muscarinic acetylcholine receptor in Alzheimer’s disease
Louis Dwomoh, Gonzalo S. Tejeda, Andrew Tobin
Neuronal Signaling (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 34
Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics
Divya Yadav, Pravir Kumar
Neurochemistry International (2022) Vol. 156, pp. 105327-105327
Closed Access | Times Cited: 32
Striatal Synaptic Dysfunction in Dystonia and Levodopa-Induced Dyskinesia
Mariangela Scarduzio, Ellen J. Hess, David G. Standaert, et al.
Neurobiology of Disease (2022) Vol. 166, pp. 105650-105650
Open Access | Times Cited: 28
Label free impedance based acetylcholinesterase enzymatic biosensors for the detection of acetylcholine
Jie Chen, Kai‐Chun Lin, Shalini Prasad, et al.
Biosensors and Bioelectronics (2023) Vol. 235, pp. 115340-115340
Open Access | Times Cited: 19
Pedunculopontine Nucleus Degeneration Contributes to Both Motor and Non-Motor Symptoms of Parkinson’s Disease
Nicole Chambers, Kathryn Lanza, Christopher Bishop
Frontiers in Pharmacology (2020) Vol. 10
Open Access | Times Cited: 41
An overview of recent analysis and detection of acetylcholine
Xuan Gu, Xiaoying Wang
Analytical Biochemistry (2021) Vol. 632, pp. 114381-114381
Closed Access | Times Cited: 37
Patterned Au@Ag nanoarrays with electrically stimulated laccase-mimicking activity for dual-mode detection of epinephrine
Anni Cui, Jialü Zhang, Zhifei Liu, et al.
Talanta (2024) Vol. 272, pp. 125821-125821
Closed Access | Times Cited: 5
A New Acetylcholine Optical Fiber Biosensor Based on Gold Film-GNRs Resonance Coupling Enhancement
Yumei Zhang, Liyun Ding, Shiyuan Wang, et al.
IEEE Sensors Journal (2024) Vol. 24, Iss. 4, pp. 4557-4564
Closed Access | Times Cited: 4
Recent Advances in the Pharmacology of Tardive Dyskinesia
Stanley N. Caroff
Clinical Psychopharmacology and Neuroscience (2020) Vol. 18, Iss. 4, pp. 493-506
Open Access | Times Cited: 24
Two Players in the Field: Hierarchical Model of Interaction between the Dopamine and Acetylcholine Signaling Systems in the Striatum
J Mysliveček
Biomedicines (2021) Vol. 9, Iss. 1, pp. 25-25
Open Access | Times Cited: 21
Localized Surface Plasmon Resonance- Based Fiber Optic Biosensor for Acetylcholine Detection
Yumei Zhang, Liyun Ding, Jue Zhao, et al.
IEEE Sensors Journal (2023) Vol. 23, Iss. 21, pp. 25987-25995
Closed Access | Times Cited: 8
Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease
Cynthia Kwan, Imane Frouni, Dominique Bédard, et al.
European Journal of Pharmacology (2020) Vol. 871, pp. 172914-172914
Closed Access | Times Cited: 21
Levodopa Causes Striatal Cholinergic Interneuron Burst‐Pause Activity in Parkinsonian Mice
Rodrigo Manuel Paz, Cecilia Tubert, Agostina M Stahl, et al.
Movement Disorders (2021) Vol. 36, Iss. 7, pp. 1578-1591
Closed Access | Times Cited: 19
Cholinergic Receptor Modulation as a Target for Preventing Dementia in Parkinson’s Disease
Alexandre Iarkov, Cristhian Mendoza, Valentina Echeverrı́a
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 19
Striatal Dopamine D2-Muscarinic Acetylcholine M1 Receptor–Receptor Interaction in a Model of Movement Disorders
René A. J. Crans, Elise Wouters, Marta Valle-León, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 18
D1/D5 Inverse Agonists Restore Striatal Cholinergic Interneuron Physiology in Dyskinetic Mice
Rodrigo Manuel Paz, Agostina M Stahl, Lorena Rela, et al.
Movement Disorders (2022) Vol. 37, Iss. 8, pp. 1693-1706
Closed Access | Times Cited: 12
Broad Serotonergic Actions of Vortioxetine as a Promising Avenue for the Treatment of L-DOPA-Induced Dyskinesia
Carla Budrow, Kayla K. Elder, Michael Coyle, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 837-837
Open Access | Times Cited: 6
Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned rats
Alberto Brugnoli, Clarissa Anna Pisanò, Michele Morari
Neurobiology of Disease (2020) Vol. 144, pp. 105044-105044
Open Access | Times Cited: 16
Effects of pedunculopontine nucleus cholinergic lesion on gait and dyskinesia in hemiparkinsonian rats
Nicole Chambers, Michael Coyle, Jordan Sergio, et al.
European Journal of Neuroscience (2021) Vol. 53, Iss. 8, pp. 2835-2847
Closed Access | Times Cited: 15
The multimodal serotonin compound Vilazodone alone, but not combined with the glutamate antagonist Amantadine, reduces l-DOPA-induced dyskinesia in hemiparkinsonian rats
Sophie R. Cohen, Michelle L. Terry, Michael Coyle, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 217, pp. 173393-173393
Closed Access | Times Cited: 10
Pharmacological targeting of G protein-coupled receptor heteromers
Estefanía Moreno, Nil Casajuana‐Martin, Michael Coyle, et al.
Pharmacological Research (2022) Vol. 185, pp. 106476-106476
Open Access | Times Cited: 10
Mechanisms of Antiparkinsonian Anticholinergic Therapy Revisited
Rodrigo Manuel Paz, M. Gustavo Murer
Neuroscience (2021) Vol. 467, pp. 201-217
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top